| Secondary |
| Hypertension |
26.6% |
| Drug Use For Unknown Indication |
18.5% |
| Atrial Fibrillation |
6.5% |
| Product Used For Unknown Indication |
5.4% |
| Arthralgia |
4.7% |
| Asthma |
4.7% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Diabetes Mellitus |
4.7% |
| Prophylaxis |
2.8% |
| Salivary Hypersecretion |
2.8% |
| Antiplatelet Therapy |
2.3% |
| Breast Cancer |
2.3% |
| Constipation |
2.3% |
| Angina Pectoris |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Lower Respiratory Tract Infection |
1.9% |
| Gout |
1.6% |
| Cardiac Failure Congestive |
1.4% |
| Rhinitis Allergic |
1.4% |
| Hypothyroidism |
1.2% |
|
| Renal Failure Acute |
12.7% |
| Pleural Effusion |
8.5% |
| Weight Fluctuation |
8.5% |
| Hyponatraemia |
7.0% |
| Obesity |
7.0% |
| Off Label Use |
7.0% |
| Circulatory Collapse |
4.2% |
| Drug Interaction |
4.2% |
| Pyrexia |
4.2% |
| Renal Failure |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Tremor |
4.2% |
| Wound Haemorrhage |
4.2% |
| Blood Pressure Increased |
2.8% |
| Dry Mouth |
2.8% |
| Fall |
2.8% |
| Hypoglycaemia |
2.8% |
| Mouth Ulceration |
2.8% |
| Orthostatic Hypotension |
2.8% |
| Pancreatitis Acute |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.1% |
| Product Used For Unknown Indication |
22.9% |
| Hypertension |
18.6% |
| Rheumatoid Arthritis |
7.8% |
| Pain |
2.8% |
| Blood Pressure Increased |
2.1% |
| Depression |
2.1% |
| Asthma |
2.0% |
| Prophylaxis |
1.7% |
| Schizophrenia |
1.6% |
| Diabetes Mellitus |
1.5% |
| Urinary Tract Infection |
1.4% |
| Colorectal Cancer |
1.2% |
| Atrial Fibrillation |
1.2% |
| Blood Pressure |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Breast Cancer Metastatic |
1.0% |
| Constipation |
1.0% |
| Osteoporosis |
0.9% |
| Angina Pectoris |
0.9% |
|
| Renal Failure Acute |
15.3% |
| Vomiting |
9.2% |
| Cerebrovascular Accident |
6.3% |
| Urinary Tract Infection |
6.3% |
| Death |
5.8% |
| Nausea |
5.5% |
| Syncope |
5.2% |
| Drug Interaction |
4.9% |
| Pulmonary Fibrosis |
4.0% |
| Myocardial Infarction |
3.7% |
| Myoclonus |
3.7% |
| Neutropenic Sepsis |
3.7% |
| Renal Failure |
3.7% |
| Sepsis |
3.7% |
| Pneumonia |
3.5% |
| Vision Blurred |
3.5% |
| Dyspnoea |
3.2% |
| Palpitations |
2.9% |
| Pulmonary Embolism |
2.9% |
| Somnolence |
2.9% |
|
| Interacting |
| Hypertension |
36.1% |
| Cardiac Failure Congestive |
20.8% |
| Atrial Fibrillation |
6.9% |
| Urinary Tract Infection |
6.9% |
| Product Used For Unknown Indication |
5.6% |
| Depression |
2.8% |
| Mania |
2.8% |
| Neuralgia |
2.8% |
| Osteoporosis |
2.8% |
| Tooth Disorder |
2.8% |
| Affective Disorder |
1.4% |
| Agitation |
1.4% |
| Antiplatelet Therapy |
1.4% |
| Dyspepsia |
1.4% |
| Essential Hypertension |
1.4% |
| Mood Altered |
1.4% |
| Oesophageal Disorder |
1.4% |
|
| Blood Sodium Decreased |
11.8% |
| Drug Interaction |
11.8% |
| Urinary Hesitation |
11.8% |
| Blood Creatinine Increased |
5.9% |
| Blood Potassium Decreased |
5.9% |
| Blood Urea Decreased |
5.9% |
| Confusional State |
5.9% |
| Convulsion |
5.9% |
| Head Injury |
5.9% |
| Hyponatraemia |
5.9% |
| Nausea |
5.9% |
| Syncope |
5.9% |
| Transient Ischaemic Attack |
5.9% |
| Vomiting |
5.9% |
|
